Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

[1]  S. Crotty,et al.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation , 2010, Nature Immunology.

[2]  H. T. ten Hulscher,et al.  Long-term presence of memory B-cells specific for different vaccine components. , 2009, Vaccine.

[3]  F. Delbos,et al.  Multiple layers of B cell memory with different effector functions , 2009, Nature Immunology.

[4]  G. Dore,et al.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. , 2009, Vaccine.

[5]  B. Volpe,et al.  XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development , 2009, The Journal of experimental medicine.

[6]  H. Hallander,et al.  Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti‐Fim2/3 antibodies after vaccination and infection , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  F. Mooi,et al.  Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence , 2009, Emerging infectious diseases.

[8]  F. Mooi,et al.  Improving pertussis vaccination , 2009, Human vaccines.

[9]  C. Siegrist,et al.  B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.

[10]  M. Littmann,et al.  Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  R. Ahmed,et al.  Requirement of B Cells for Generating CD4+ T Cell Memory1 , 2009, The Journal of Immunology.

[12]  F. Mooi,et al.  Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin , 2008, Infection and Immunity.

[13]  C. V. van Els,et al.  Hyperproliferation of B Cells Specific for a Weakly Immunogenic PorA in a Meningococcal Vaccine Model , 2008, Clinical and Vaccine Immunology.

[14]  G. Berbers,et al.  Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. , 2008, Journal of immunological methods.

[15]  J. Mertsola,et al.  Factors contributing to pertussis resurgence. , 2008, Future microbiology.

[16]  J. Wrammert,et al.  Maintenance of serological memory , 2008, Biological chemistry.

[17]  Mark J. Shlomchik,et al.  Maintenance of the plasma cell pool is independent of memory B cells , 2008, Proceedings of the National Academy of Sciences.

[18]  R. Geha,et al.  Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL1 , 2008, The Journal of Immunology.

[19]  D. Kelly,et al.  The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response1 , 2008, The Journal of Immunology.

[20]  M. Thalen,et al.  Improving the cellular pertussis vaccine: increased potency and consistency. , 2008, Vaccine.

[21]  Nichole E Carlson,et al.  Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.

[22]  N. Carbonetti.  Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. , 2007, Current opinion in pharmacology.

[23]  N. Guiso,et al.  Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. , 2007, Vaccine.

[24]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[25]  D. Knipe,et al.  Optimal Long-Term Humoral Responses to Replication-Defective Herpes Simplex Virus Require CD21/CD35 Complement Receptor Expression on Stromal Cells , 2006, Journal of Virology.

[26]  M. Tomayko,et al.  Intrinsic properties of human and murine memory B cells , 2006, Immunological reviews.

[27]  R. Ahmed,et al.  Differentiation of memory B and T cells. , 2006, Current opinion in immunology.

[28]  D. Gray,et al.  Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells1 , 2006, The Journal of Immunology.

[29]  D. Kelly,et al.  Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. , 2005, JAMA.

[30]  H. Hallander,et al.  Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. , 2005, Vaccine.

[31]  Aaron M Wendelboe,et al.  Duration of Immunity Against Pertussis After Natural Infection or Vaccination , 2005, The Pediatric infectious disease journal.

[32]  P. Mastrantonio,et al.  Bordetella pertussis-Infected Human Monocyte-Derived Dendritic Cells Undergo Maturation and Induce Th1 Polarization and Interleukin-23 Expression , 2005, Infection and Immunity.

[33]  P. Lipsky,et al.  Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61 , 2004, The Journal of Immunology.

[34]  D. Greenberg,et al.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. , 2004, The Journal of infectious diseases.

[35]  J. Mertsola,et al.  Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  R. Ahmed,et al.  Immunological memory in humans. , 2004, Seminars in immunology.

[37]  D. Rabczenko,et al.  Pertussis in Poland. , 2004, International journal of epidemiology.

[38]  R. Ahmed,et al.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.

[39]  D. Golenbock,et al.  Haemophilus influenzae Type b-Outer Membrane Protein Complex Glycoconjugate Vaccine Induces Cytokine Production by Engaging Human Toll-Like Receptor 2 (TLR2) and Requires the Presence of TLR2 for Optimal Immunogenicity1 , 2004, The Journal of Immunology.

[40]  K. Mills,et al.  Molecules of infectious agents as immunomodulatory drugs. , 2004, Current topics in medicinal chemistry.

[41]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[42]  David Goldblatt,et al.  Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom , 2003, Infection and Immunity.

[43]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[44]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[45]  M. Frosch,et al.  Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. , 2001, Vaccine.

[46]  K. Mills.  Immunity to Bordetella pertussis. , 2001, Microbes and infection.

[47]  P. Rigsby,et al.  International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[48]  K. Elkins,et al.  Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production , 2000, The Journal of experimental medicine.

[49]  K. Mills,et al.  Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. , 2000, The Journal of infectious diseases.

[50]  S. Salmaso,et al.  Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines , 1999, Infection and Immunity.

[51]  M. Brennan,et al.  Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  H. Hallander,et al.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. , 1998, Vaccine.

[53]  J. Gornbein,et al.  A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. , 1998, Vaccine.

[54]  Ả. Svensson,et al.  Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991. , 1998, International journal of epidemiology.

[55]  S. Salmaso,et al.  Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. , 1998, Vaccine.

[56]  S. Salmaso,et al.  Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. , 1998, The Journal of pediatrics.

[57]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[58]  F. Mooi,et al.  The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. , 1998, Vaccine.

[59]  M. Thalen,et al.  Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA. , 1997, Journal of immunoassay.

[60]  R. Andrews,et al.  Pertussis notifications in Australia, 1991 to 1997. , 1997, Communicable diseases intelligence.

[61]  K. Toellner,et al.  The changing preference of T and B cells for partners as T‐dependent antibody responses develop , 1997, Immunological reviews.

[62]  F. Mooi,et al.  Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. , 1997, Emerging infectious diseases.

[63]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[64]  F. Ennis,et al.  Human cytotoxic T-cell memory: long-lived responses to vaccinia virus , 1996, Journal of virology.

[65]  G. De Serres,et al.  Pertussis in Quebec: ongoing epidemic since the late 1980s. , 1995, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[66]  J. W. Bass,et al.  Return of epidemic pertussis in the United States. , 1994, The Pediatric infectious disease journal.

[67]  K. Edwards,et al.  Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. , 1992, The Journal of pediatrics.

[68]  T. Schwartz,et al.  The persistence of neutralizing antibodies after revaccination against smallpox. , 1990, The Journal of infectious diseases.

[69]  S. Funnell,et al.  Serospecific protection of mice against intranasal infection with Bordetella pertussis. , 1989, Vaccine.

[70]  O. Mäkelä,et al.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG. , 1989, The Journal of infectious diseases.

[71]  B. Meade,et al.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. , 1983, The Journal of biological chemistry.

[72]  H. Sato,et al.  Separation and purification of the hemagglutinins from Bordetella pertussis , 1983, Infection and immunity.

[73]  L. McHeyzer-Williams,et al.  Antigen-specific memory B cell development. , 2005, Annual review of immunology.

[74]  E. Miller,et al.  Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. , 1997, Vaccine.

[75]  P. Ibsen,et al.  Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine. , 1993, Vaccine.